APO Research
Talk to an analyst

APO RESEARCH · REPORT

Infertility Drugs

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.

Selected research

Market Outlook & Growth Opportunities

Global Infertility Drugs Market Outlook and Growth Opportunities 2026

21 December 2025190 pages

Choose your research edition.

Industry ResearchInfertility Drugs Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Infertility Drugs Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Infertility Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Infertility Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Infertility Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.

Global Infertility Drugs key players include LIVZON, Merck, Abbott, Ferring, etc. Global top four manufacturers hold a share about 45%.

North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 35 percent.

Read the full market overview

In terms of product, Gonadotropins is the largest segment, with a share nearly 80%. And in terms of application, the largest application is Female, followed by Male.

This report provides an overview of the global Infertility Drugs market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Infertility Drugs and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Infertility Drugs revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Infertility Drugs market.

Infertility Drugs Segment by Company

Merck

Ferring

MSD

LIVZON

Abbott

Bayer Zydus Pharma

Infertility Drugs Segment by Type

Gonadotropins

Anti-Estrogens

Other

Infertility Drugs Segment by Application

Male

Female

Infertility Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Infertility Drugs status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Infertility Drugs key companies, revenue, market share, and recent developments.

3. To split the Infertility Drugs breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Infertility Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Infertility Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Infertility Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Infertility Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Infertility Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Infertility Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Infertility Drugs industry.

Chapter 3: Detailed analysis of Infertility Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Infertility Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Infertility Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Infertility Drugs Industry Trends Table 2. Infertility Drugs Industry Drivers Table 3. Infertility Drugs Industry Opportunities and Challenges Table 4. Infertility Drugs Industry Restraints Table 5. Global Infertility Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Infertility Drugs Revenue Share by Company (2021-2026) Table 7. Global Infertility Drugs Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Infertility Drugs Key Company Manufacturing Base & Headquarters Table 9. Global Infertility Drugs Company, Product Type & Application Table 10. Global Infertility Drugs Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Infertility Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Gonadotropins Table 15. Significant Companies of Anti-Estrogens Table 16. Significant Companies of Other Table 17. Global Infertility Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Infertility Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Infertility Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Infertility Drugs Sales Value Share by Type (2021-2026) Table 21. Global Infertility Drugs Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Male Table 23. Significant Companies of Female Table 24. Global Infertility Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Infertility Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Infertility Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Infertility Drugs Sales Value Share by Application (2021-2026) Table 28. Global Infertility Drugs Sales Value Share by Application (2027-2032) Table 29. Global Infertility Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Infertility Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Infertility Drugs Sales Value Share by Region (2021-2026) Table 32. Global Infertility Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Infertility Drugs Sales Value Share by Region (2027-2032) Table 34. Global Infertility Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Infertility Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Infertility Drugs Sales Value Market Share by Country (2021-2026) Table 37. Global Infertility Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Infertility Drugs Sales Value Market Share by Country (2027-2032) Table 39. Merck Company Information Table 40. Merck Business Overview Table 41. Merck Infertility Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Merck Infertility Drugs Product Portfolio Table 43. Merck Recent Development Table 44. Ferring Company Information Table 45. Ferring Business Overview Table 46. Ferring Infertility Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Ferring Infertility Drugs Product Portfolio Table 48. Ferring Recent Development Table 49. MSD Company Information Table 50. MSD Business Overview Table 51. MSD Infertility Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. MSD Infertility Drugs Product Portfolio Table 53. MSD Recent Development Table 54. LIVZON Company Information Table 55. LIVZON Business Overview Table 56. LIVZON Infertility Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. LIVZON Infertility Drugs Product Portfolio Table 58. LIVZON Recent Development Table 59. Abbott Company Information Table 60. Abbott Business Overview Table 61. Abbott Infertility Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Abbott Infertility Drugs Product Portfolio Table 63. Abbott Recent Development Table 64. Bayer Zydus Pharma Company Information Table 65. Bayer Zydus Pharma Business Overview Table 66. Bayer Zydus Pharma Infertility Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Bayer Zydus Pharma Infertility Drugs Product Portfolio Table 68. Bayer Zydus Pharma Recent Development Table 69. Research Programs/Design for This Report Table 70. Authors List of This Report Table 71. Secondary Sources Table 72. Primary Sources List of Figures Figure 1. Infertility Drugs Product Image Figure 2. Global Infertility Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Infertility Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Infertility Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Gonadotropins Image Figure 8. Anti-Estrogens Image Figure 9. Other Image Figure 10. Global Infertility Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Infertility Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Infertility Drugs Sales Value Share by Type (2021-2032) Figure 13. Male Image Figure 14. Female Image Figure 15. Global Infertility Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Infertility Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Infertility Drugs Sales Value Share by Application (2021-2032) Figure 18. Global Infertility Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Infertility Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Infertility Drugs Sales Value (2021-2032) & (US$ Million) Figure 21. North America Infertility Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Infertility Drugs Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Infertility Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Infertility Drugs Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Infertility Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Infertility Drugs Sales Value (2021-2032) & (US$ Million) Figure 27. South America Infertility Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Infertility Drugs Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Infertility Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Infertility Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Infertility Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Infertility Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Gonadotropins
  • Anti-Estrogens
  • Other
Applications
  • Male
  • Female
Companies covered
  • Merck
  • Ferring
  • MSD
  • LIVZON
  • Abbott
  • Bayer Zydus Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Infertility Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Infertility Drugs Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Infertility Drugs Market Dynamics
  1. 2.1 Infertility Drugs Industry Trends
  2. 2.2 Infertility Drugs Industry Drivers
  3. 2.3 Infertility Drugs Industry Opportunities and Challenges
  4. 2.4 Infertility Drugs Industry Restraints
3 Infertility Drugs Market by Company
  1. 3.1 Global Infertility Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Infertility Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Infertility Drugs Company Ranking (2024-2026)
  4. 3.4 Global Infertility Drugs Company Manufacturing Base and Headquarters
  5. 3.5 Global Infertility Drugs Company Product Type and Application
  6. 3.6 Global Infertility Drugs Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Infertility Drugs Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Infertility Drugs Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Infertility Drugs Market by Type
  1. 4.1 Infertility Drugs Type Introduction
  2. 4.1.1 Gonadotropins
  3. 4.1.2 Anti-Estrogens
  4. 4.1.3 Other
  5. 4.2 Global Infertility Drugs Sales Value by Type
  6. 4.2.1 Global Infertility Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Infertility Drugs Sales Value by Type (2021-2032)
  8. 4.2.3 Global Infertility Drugs Sales Value Share by Type (2021-2032)
5 Infertility Drugs Market by Application
  1. 5.1 Infertility Drugs Application Introduction
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global Infertility Drugs Sales Value by Application
  5. 5.2.1 Global Infertility Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Infertility Drugs Sales Value by Application (2021-2032)
  7. 5.2.3 Global Infertility Drugs Sales Value Share by Application (2021-2032)
6 Infertility Drugs Regional Value Analysis
  1. 6.1 Global Infertility Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Infertility Drugs Sales Value by Region (2021-2032)
  3. 6.2.1 Global Infertility Drugs Sales Value by Region: 2021-2026
  4. 6.2.2 Global Infertility Drugs Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Infertility Drugs Sales Value (2021-2032)
  7. 6.3.2 North America Infertility Drugs Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Infertility Drugs Sales Value (2021-2032)
  10. 6.4.2 Europe Infertility Drugs Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Infertility Drugs Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Infertility Drugs Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Infertility Drugs Sales Value (2021-2032)
  16. 6.6.2 South America Infertility Drugs Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Infertility Drugs Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Infertility Drugs Sales Value Share by Country, 2025 VS 2032
7 Infertility Drugs Country-level Value Analysis
  1. 7.1 Global Infertility Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Infertility Drugs Sales Value by Country (2021-2032)
  3. 7.2.1 Global Infertility Drugs Sales Value by Country (2021-2026)
  4. 7.2.2 Global Infertility Drugs Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Infertility Drugs Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Infertility Drugs Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Infertility Drugs Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Infertility Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Infertility Drugs Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Infertility Drugs Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Infertility Drugs Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Infertility Drugs Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Infertility Drugs Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Infertility Drugs Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Infertility Drugs Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Infertility Drugs Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Infertility Drugs Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Infertility Drugs Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Infertility Drugs Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Infertility Drugs Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Infertility Drugs Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Infertility Drugs Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Infertility Drugs Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Infertility Drugs Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Infertility Drugs Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Infertility Drugs Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Infertility Drugs Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Infertility Drugs Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Infertility Drugs Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Infertility Drugs Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Infertility Drugs Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Infertility Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Infertility Drugs Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Infertility Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Infertility Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Infertility Drugs Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Infertility Drugs Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Ferring
  8. 8.2.1 Ferring Company Information
  9. 8.2.2 Ferring Business Overview
  10. 8.2.3 Ferring Infertility Drugs Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ferring Infertility Drugs Product Portfolio
  12. 8.2.5 Ferring Recent Developments
  13. 8.3 MSD
  14. 8.3.1 MSD Company Information
  15. 8.3.2 MSD Business Overview
  16. 8.3.3 MSD Infertility Drugs Revenue and Gross Margin (2021-2026)
  17. 8.3.4 MSD Infertility Drugs Product Portfolio
  18. 8.3.5 MSD Recent Developments
  19. 8.4 LIVZON
  20. 8.4.1 LIVZON Company Information
  21. 8.4.2 LIVZON Business Overview
  22. 8.4.3 LIVZON Infertility Drugs Revenue and Gross Margin (2021-2026)
  23. 8.4.4 LIVZON Infertility Drugs Product Portfolio
  24. 8.4.5 LIVZON Recent Developments
  25. 8.5 Abbott
  26. 8.5.1 Abbott Company Information
  27. 8.5.2 Abbott Business Overview
  28. 8.5.3 Abbott Infertility Drugs Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Abbott Infertility Drugs Product Portfolio
  30. 8.5.5 Abbott Recent Developments
  31. 8.6 Bayer Zydus Pharma
  32. 8.6.1 Bayer Zydus Pharma Company Information
  33. 8.6.2 Bayer Zydus Pharma Business Overview
  34. 8.6.3 Bayer Zydus Pharma Infertility Drugs Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Zydus Pharma Infertility Drugs Product Portfolio
  36. 8.6.5 Bayer Zydus Pharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst